Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-26 @ 10:17 PM
Study NCT ID:
NCT01271712
Status:
COMPLETED
Last Update Posted:
2021-01-29
First Post:
2010-12-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-04
Start Date Type:
ACTUAL
Primary Completion Date:
2012-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-15
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-17
First Submit QC Date:
None
Study First Post Date:
2011-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-05-24
Results First Submit QC Date:
None
Results First Post Date:
2013-10-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-02-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-01-27
Last Update Post Date:
2021-01-29
Last Update Post Date Type:
ACTUAL